Double Helix of breast cancer therapy: intertwining the Halsted and Fisher hypotheses

Editorial

Rachel Rabinovitch et al. J Clin Oncol. 2009.

. 2009 May 20;27(15):2422-3.

doi: 10.1200/JCO.2009.21.8453. Epub 2009 Apr 6.

No abstract available

Comment in

The breast cancer alternative hypothesis: is there evidence to justify replacing it?
Fisher B, Anderson SJ. Fisher B, et al. J Clin Oncol. 2010 Jan 20;28(3):366-74. doi: 10.1200/JCO.2009.26.8292. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008611 No abstract available.
Local control, survival, and the Fisher hypothesis.
Margolese RG. Margolese RG. J Clin Oncol. 2010 Jan 20;28(3):e39; author reply e40. doi: 10.1200/JCO.2009.24.6520. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008629 No abstract available.

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP, Wolmark N. Anderson SJ, et al. J Clin Oncol. 2009 May 20;27(15):2466-73. doi: 10.1200/JCO.2008.19.8424. Epub 2009 Apr 6. J Clin Oncol. 2009. PMID: 19349544 Free PMC article. Clinical Trial.